IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+0.62%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$437M
AUM Growth
+$437M
(-22%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-28.81%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
211
New
18
Increased
20
Reduced
105
Closed
27
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21.9M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$11.5M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$9.39M |
| 4 |
Immatics
IMTX
|
$8.55M |
| 5 |
Zentalis Pharmaceuticals
ZNTL
|
$6.15M |
Top Sells
| 1 |
Biogen
BIIB
|
$26.5M |
| 2 |
Alector
ALEC
|
$14.1M |
| 3 |
CRISPR Therapeutics
CRSP
|
$10.3M |
| 4 |
Annovis Bio
ANVS
|
$8.86M |
| 5 |
Cullinan Oncology
CGEM
|
$7.61M |
Sector Composition
| 1 | Healthcare | 97.59% |
| 2 | Consumer Staples | 0.77% |
| 3 | Technology | 0.56% |
| 4 | Financials | 0.17% |
| 5 | Real Estate | 0% |
